当前位置：首页 > 文献互助 > 互助详情

期刊论文Clinical Efficacy and Influencing Factors of Apatinib Combined With Sintilimab in the Treatment of Advanced Non‐Small‐Cell Lung Cancer复制

用户EO9nReo4Hj6s 54分钟前 19 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-09-11 14:57:13 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1111/ajco.70165复制

文献链接: https://onlinelibrary.wiley.com/doi/10.1111/ajco.70165复制

其他信息:

出版社: Wiley
作者: Yuan Zhang; Jiao Zhang
全文下载地址: https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.70165

上一篇：COL1A1 modulates apatinib sensitivity through promoting glycolysis and angiogenesis in gastric cancer cells

下一篇：Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial

互助时间线

2026-09-04 15:02:51 [完结求助]

楼主确认了皮一下XD应助的文件是正确的, 求助状态变成已完结

2026-09-04 14:57:13 [上传文件]

皮一下XD上传了文件(pdf 973.72 KB), 求助状态变成待确认

2026-09-04 14:38:22 [发起求助]

最新发布的求助

Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression 8分钟前

Synthesis of Mesoporous Catechin Nanoparticles as Biocompatible Drug-Free Antibacterial Mesoformulation 17分钟前

Preparation and properties of some organotin compounds : I. Dibutyltin glycolates 22分钟前

TMEM184A-mediated autophagy in MHC-I degradation promotes tumor immune evasion 29分钟前

Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial 37分钟前

Clinical Efficacy and Influencing Factors of Apatinib Combined With Sintilimab in the Treatment of Advanced Non‐Small‐Cell Lung Cancer 54分钟前

COL1A1 modulates apatinib sensitivity through promoting glycolysis and angiogenesis in gastric cancer cells 56分钟前

Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study 58分钟前

Effect of Rivoceranib 200 mg Once Daily on the Pharmacokinetics of a Cocktail Probe Substrate of Cytochrome P450 Enzymes: A Phase I Trial in Healthy Volunteers 1小时前

Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial 1小时前

Causes, Risk Analysis, and Countermeasures of Urban Road Collapse in China from 2019 to 2020 1小时前

Post-herpetic neuralgia 1小时前